Back

Single-Cell Multiomic Profiling Uncovers Radiation Dosage-Sensitive, Cluster-Specific Regulatory Dynamics in Glioblastoma

Huynh, K.; Barcik Weissman, S. N.; Park, C.; Quiloan, M. L. G.; Chang, B. S.; Chang, E.; Street, K.; Tran, D.; Modrek, A. S.

2025-12-03 cancer biology
10.64898/2025.12.01.691699 bioRxiv
Show abstract

Glioblastoma (GBM) is an aggressive brain tumor that inevitably recurs after chemoradiotherapy, resulting in poor patient outcomes. Given GBMs cellular heterogeneity, we hypothesized that radiation induces sub-population specific alterations to survive and adapt to radiation stress. We performed integrated single-cell RNA-seq and ATAC-seq analyses in Glioma Stem-Like Cultures three hours after they were exposed to clinically relevant radiation doses. Radiation reshaped the cellular landscape, altering both cell type composition and GBM subtype distribution. Cluster-specific and shared transcriptional programs were induced in a dose-dependent manner, with differentially expressed genes enriching distinct biological pathways. Chromatin accessibility analyses revealed parallel cluster-specific remodeling, with both opening and closing of regulatory elements linked to functional pathway shifts. Notably, 2 Gy and 6 Gy exposures elicited conserved transcriptional profiles in RNA clusters across different radiation doses. Together, these results highlight immediate radiation-induced transcriptional and chromatin remodeling programs in GBM at single-cell resolution and identify conserved cluster-specific adaptations that may underlie therapeutic resistance.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
Radiotherapy and Oncology
○ 19 papers in training set
Top 0.1%
15.5%
Similar papers in this journal
2
Scientific Reports
○ 3612 papers in training set
Top 1%
15.5%
Similar papers in this journal
3
International Journal of Radiation Oncology*Biology*Physics
○ 25 papers in training set
Top 0.1%
13.0%
Similar papers in this journal
4
Nature Communications
○ 5641 papers in training set
Top 23%
6.9%
Similar papers in this journal
50% of probability mass above
5
eLife
● 5828 papers in training set
Top 27%
4.4%
Similar papers in this journal
6
Communications Biology
○ 993 papers in training set
Top 5%
3.2%
7
Cancer Research Communications
● 51 papers in training set
Top 0.5%
2.5%
8
Neuro-Oncology
◐ 36 papers in training set
Top 0.3%
2.4%
9
Molecular Cancer Research
● 49 papers in training set
Top 0.4%
2.4%
10
PLOS ONE
● 5266 papers in training set
Top 42%
2.2%
11
Cancers
○ 213 papers in training set
Top 3%
1.8%
12
iScience
○ 1154 papers in training set
Top 16%
1.8%
13
npj Precision Oncology
○ 53 papers in training set
Top 1.0%
1.5%
14
Epigenetics
○ 50 papers in training set
Top 0.4%
1.4%
15
Cancer Research
● 130 papers in training set
Top 2%
1.2%
16
International Journal of Cancer
○ 49 papers in training set
Top 0.8%
1.2%
17
Cell Reports
○ 1498 papers in training set
Top 22%
1.2%
18
Science Advances
● 1243 papers in training set
Top 24%
1.2%
19
Molecular Cancer Therapeutics
● 40 papers in training set
Top 0.6%
1.2%
20
Medical Physics
○ 14 papers in training set
Top 0.4%
1.1%
21
Proceedings of the National Academy of Sciences
● 2444 papers in training set
Top 39%
0.9%
22
BMC Cancer
○ 67 papers in training set
Top 2%
0.9%
23
Advanced Science
○ 286 papers in training set
Top 9%
0.9%
24
Cancer Letters
○ 35 papers in training set
Top 1%
0.9%
25
Oncotarget
○ 18 papers in training set
Top 0.4%
0.9%
26
Biochemistry and Biophysics Reports
○ 30 papers in training set
Top 1%
0.9%
27
Genome Biology
○ 637 papers in training set
Top 8%
0.9%
28
Clinical Cancer Research
● 64 papers in training set
Top 2%
0.6%
29
Theranostics
● 37 papers in training set
Top 1%
0.6%
30
JNCI: Journal of the National Cancer Institute
◐ 19 papers in training set
Top 0.4%
0.6%

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.